Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-06-17 @ 1:01 AM
Study NCT ID:
NCT06393751
Status:
WITHDRAWN
Last Update Posted:
2025-06-03
First Post:
2024-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer
Sponsor:
Organization: